Advertisement
Singapore markets open in 7 hours 18 minutes

  • Straits Times Index

    3,272.72
    +47.55 (+1.47%)
     

  • S&P 500

    5,072.09
    +61.49 (+1.23%)
     

  • Dow

    38,542.17
    +302.19 (+0.79%)
     

  • Nasdaq

    15,694.78
    +243.47 (+1.58%)
     

  • Bitcoin USD

    66,737.24
    +101.08 (+0.15%)
     

  • CMC Crypto 200

    1,435.67
    +20.91 (+1.48%)
     

  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     

  • Gold

    2,340.50
    -5.90 (-0.25%)
     

  • Crude Oil

    83.19
    +1.29 (+1.58%)
     

  • 10-Yr Bond

    4.5880
    -0.0350 (-0.76%)
     

  • Nikkei

    37,552.16
    +113.55 (+0.30%)
     

  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     

  • FTSE Bursa Malaysia

    1,561.64
    +2.05 (+0.13%)
     

  • Jakarta Composite Index

    7,110.81
    +36.99 (+0.52%)
     

  • PSE Index

    6,506.80
    +62.72 (+0.97%)
     

Teva settles with Oklahoma for $85 million in opioid case

Associated Press

NORMAN, Okla. (AP) — One of the drugmakers named in Oklahoma's lawsuit over the opioid crisis has agreed to a settlement in which it will pay the state $85 million.

Israeli-owned Teva Pharmaceuticals and Oklahoma Attorney General Mike Hunter both announced the settlement Sunday in separate statements. Teva, its related affiliates and Johnson & Johnson and several of its subsidiaries were set to go to trial Tuesday in Norman.

Hunter said the case against Johnson & Johnson will proceed on schedule.

He also said the funds from the settlement with Teva will be used to fight the opioid crisis in Oklahoma.

Teva did not admit any wrongdoing under the settlement.

Earlier this year, Oklahoma settled with OxyContin-maker Purdue Pharma for $270 million.